Skip to content

Comparison of two devices Proseal LMA and Ambu Auragain LMA in laparoscopic cholecystectomy for anaesthesia

Comparison of Proseal LMA and Ambu Auragain LMA in patients undergoing laparoscopic cholecystectomy

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/10/016085
Enrollment
80
Registered
2018-10-18
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- ASA ( American society of Anaesthesiologist) grade 1 and 2 Health Condition 2: K819- Cholecystitis, unspecified

Interventions

Intervention1: AURAGAIN LMA: New second generation supraglottic airway device It has an incorporated gastric drainage channel. Control Intervention1: Proseal LMA: Second generation double lumen double

Sponsors

AIIMS Raipur
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. ASA physical status grade I and II 2. Patients of either sex 3. 18 â?? 65 years of age 4. BMI â?? 18.5 â?? 30 5. Patients undergoing laparoscopic cholecystectomy under general anaesthesia (1-2 hours duration)

Exclusion criteria

Exclusion criteria: 1. Restricted mouth opening ( 2. Mallampati Grade (MPG) III/IV 3. Patients with airway morbidities (Respiratory tract infections, COPD etc) 4. Patients with BMI >30 5. Patients with risk of gastric aspiration (non-fasted, GERD) 6. Pregnant patients 7. Patient refusal

Design outcomes

Secondary

MeasureTime frame
2. Ease of insertion 3. Insertion Time (in seconds) 4. Number of attempts 5. Minimum cuff volume and pressure required to prevent leak 6. Peak and plateau airway pressure 7. Ease and size of gastric tube placement 8. Post-operative complicationsTimepoint: Introp and Post op upto 24 hrs

Primary

MeasureTime frame
Maximum airway sealing pressuresTimepoint: after putting the LMA, 5 minutes after carboperitonium, Before removal of LMA

Countries

India

Contacts

Public ContactDr Mayank Kumar

AIIMS Raipur

mayanksonupmch@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026